We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

76 hedge funds and large institutions have $294M invested in Avadel Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 24 increasing their positions, 23 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more call options, than puts

Call options by funds: $7.6M | Put options by funds: $2.97M

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

39% more capital invested

Capital invested by funds: $211M → $294M (+$83.2M)

1.01% more ownership

Funds ownership: 54.98% → 56% (+1%)

4% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 23

7% less funds holding

Funds holding: 82 → 76 (-6)

38% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 16

Holders
76
Holders Change
-6
Holders Change %
-7.32%
% of All Funds
1.33%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
10
Increased
24
Reduced
23
Closed
16
Calls
$7.6M
Puts
$2.97M
Net Calls
+$4.63M
Net Calls Change
+$4.72M

Top Buyers

Rank Fund Capital Flow
1
CAC
Cowen and Company
New York
+$4.88M
2
FM
Frazier Management
Washington
+$4.67M
3
ACP
Acuta Capital Partners
California
+$3.15M
4
RI
RTW Investments
New York
+$2.87M
5
GJL
Gendell Jeffrey L
+$2.04M

Top Sellers

Rank Fund Capital Flow
1
VC
Vivo Capital
California
-$4.76M
2
Millennium Management
Millennium Management
New York
-$2.29M
3
ACM
Asymmetry Capital Management
California
-$1.97M
4
PCH
Polar Capital Holdings
United Kingdom
-$1.88M
5
JGC
J. Goldman & Co
New York
-$1.56M
Name Holding Trade Value Shares
Change 		Change in
Stake
Daiwa Securities Group
76
Daiwa Securities Group
Japan
$1K – – –
JGC
77
J. Goldman & Co
New York
– -$1.56M -233,747 Closed
TCM
78
Tekla Capital Management
Massachusetts
– -$1.56M -233,612 Closed
IC
79
Ikarian Capital
Texas
– -$366K -54,694 Closed
PCM
80
Prelude Capital Management
New York
– -$341K -51,118 Closed
Group One Trading
81
Group One Trading
Illinois
– -$171K -21,113 Closed
VF
82
Virtu Financial
New York
– -$97K -14,461 Closed
JF
83
Jump Financial
Illinois
– -$79K -11,754 Closed
DTL
84
Dynamic Technology Lab
Singapore
– -$75K -11,299 Closed
IIA
85
IPG Investment Advisors
California
– -$72.1K -10,800 Closed
William Blair & Company
86
William Blair & Company
Illinois
– -$68K -10,250 Closed
JMPWA
87
JP Morgan Private Wealth Advisors
California
– -$67K -10,000 Closed
EDRH
88
Edmond de Rothschild Holding
Switzerland
– -$27K -4,000 Closed
QT
89
Quantbot Technologies
New York
– -$8K -1,300 Closed
ABC
90
Associated Banc-Corp
Wisconsin
– -$3K -500 Closed
FDCDDQ
91
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$134 -20 Closed
1 2 3
4

AVDL Hedge Fund Activity: Q1 2021 in Review

76 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q1 2021, worth a combined $294M — up 39% from $211M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of AVDL and 10 opened new positions — a net loss of 6 holders — while 23 trimmed existing stakes and 24 added.

The largest buyer was Cowen and Company, adding an estimated $4.88M. The largest seller was Vivo Capital, cutting an estimated $4.76M.

  • 76 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q1 2021, down from 82 in Q4 2020.
  • Funds reported $294M of Avadel Pharmaceuticals stock for Q1 2021, up 39% quarter-over-quarter.
  • 10 funds opened new Avadel Pharmaceuticals positions in Q1 2021 and 16 closed out, a net change of -6 holders.
  • The largest Avadel Pharmaceuticals buyer in Q1 2021 was Cowen and Company, an estimated $4.88M added.
  • The largest Avadel Pharmaceuticals seller in Q1 2021 was Vivo Capital, an estimated $4.76M sold.

Based on aggregated 13F filings for Q1 2021.